Arno Therapeutics Announces Poster Presentation At ASH Annual Meeting Demonstrating Anti-Leukemic Stem Cell Activity Of AR-42

Wednesday, December 16th, 2009

Arno Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology therapeutics, today announced the presentation of a poster at the annual American Society of Hematology (ASH) meeting that describes the preclinical activity of Arno's drug candidate AR-42 against leukemia stem cells (LSCs). AR-42 is a broad spectrum inhibitor ...

Posted in Healthy LifeStyle | No Comments »